Brazil Rigid PU Foam Market Size Worth $348.4 Million By 2025 | Key Industry Players BASF SE And Dow Chemical Company

San Francisco, 28 Nov 2018 - The Brazil rigid PU foam market size is poised to reach USD 348.4 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.9% during the forecast period. Surging demand from the automotive industry in the country is projected to drive the market over the forecast period.

Rigid polyurethane foam finds multiple applications across the end-use industries in Brazil because they are excellent insulation materials, which help in saving energy and also occupies minimal space. Their application scope mostly include refrigeration in the appliances industry and roofing and wall applications to reduce heat loss in the construction industry.

Apart from product formulations and technological advancements to cater to a broader customer base in the country, numerous multinational manufacturers are highly focusing on raw material suppliers to increase reach and visibility. Companies tie up with suppliers based on their presence in the local market and knowledge about marketplace, combined with their diligence in timing and accessibility.

Since the initiation of Green Building concept implementation in Brazil since 2007, the country recorded around 652 projects, which were approved or waiting for approval by 2012. The concept was backed by organizations including the Energy and Environmental Design and Green Building Council, Brazil. These funded projects are approved by Leadership in Energy and Environmental Design, an agency which operates in 175 countries ensuring minimal wastage or consumption of electricity, to record lower environmental degradation.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/brazil-rigid-polyurethane-pu-foam-market

Further key findings from the report suggest:

• On the basis of product, slabstock polyether had the largest market share and accounted for approximately 48.0% of the overall volume in 2017. The segment is anticipated to register the highest CAGR during the forecast period due to its wide scope of applications in shoe insole and textiles
• In terms of demand, the automotive industry is estimated to be the most promising application segment in the Brazil rigid PU foam market. It is expected to experience a CAGR of 4.3% during the same period, owing to wide usage of the product in multiple vehicle interior headline ceiling sections, doors & windows, and under-hood components
• Long-term relations of manufacturers with their third-party suppliers is one of the critical tactics adopted in the country to ensure broader product reach and accessibility
• Concept of green building is poised to fuel the demand for light-weight PU materials to minimize energy consumption and steps towards an eco-friendlier environment
• Multinational companies operating in the country are shifting their production process and product line to greener & more eco-friendly counterpart to cope up with stringent regulations imposed by the government
• Introduction of bio-based counterparts such as non-toxic isocyanates is projected to replace the trend of chemically derived products and petrochemical-based alternates in the foreseeable future.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Brazil rigid PU foam market on the basis of product and applications: 

Brazil Rigid PU Foam Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Slabstock Polyether
• Slabstock Polyester
• Molded Foam Parts
• Others

Brazil Rigid PU Foam Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Appliances
  • Refrigerator
  • Others
• Building & Construction
  • Sandwich Panels
  • Insulating Boards
  • Spray Foam
  • Others
• Automotive
• Others (Marine, Oil & Gas, Rail)

Browse Press Release of this Report: www.grandviewresearch.com/press-release/brazil-rigid-polyurethane-pu-foam-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gas Turbine Market Size Worth $30.08 Billion By 2025 | General Electric Company, Siemens AG

San Francisco, 28 Nov 2018 - According to a report published by Grand View Research, Inc.; the global gas turbine market is projected to reach a valuation of around USD 30.08 billion by 2025. Factors such as increasing electricity demand and pressure to reduce carbon footprint are anticipated to drive market over the forecast period (2014 to 2025). In addition, supportive government measures such as intensives offerings for natural gas-based electricity generation are also expected to fuel market growth in near future.

Turbines produce lower carbon footprint, as compared to combustion-based power generation applications. Demand for gas turbines is expected to witness a steady rise in the forthcoming years due to rising implementation of climate change drives and stern regulatory frameworks to reduce greenhouse gas emissions.

Browse More Insights On Gas Turbines Market: www.grandviewresearch.com/industry-analysis/gas-turbine-market

The worldwide turbine market can be segmented on the basis of capacity, technology, application, and region. Based on capacity, the market can be classified into ≤200 MW and >200 MW. On the basis of technology, the market can be bifurcated into open cycle and combined cycle. In terms of Revenue, combined cycle segment held over 50.0% of overall capacity in 2016. This segment is expected to exhibit high growth with an estimated CAGR of 5.0% over the forecast period. These turbines consume less fuel to produce desired output and can reduce distribution and transmission losses.

As per application, the market can be categorized into power generation, industrial, and aviation. In 2016, power generation segment was valued at USD 10.91 billion. The segment is likely to expand at a CAGR of 4.4% during the forecast period. It comprises fertilizers, pulp and paper, chemical, metal, mining, sugar, and oil and gas, and other such industries. Heavy industries segment is expected to create several business opportunities in the forthcoming years due to cost effectiveness and better efficiency of gas turbines. Installation of these turbines is expected to cut operative cost by over 35.0%.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. A large number of power station are expected to be decommissioned in North America and Europe as most power plants are in second phase of their lifecycle. In Europe, air pollution equipment of several plants have not been upgraded. Hence, Europe is likely to showcase significant rise in demand over the forecast period with a large number of thermal-based power generations being decommissioned over the forecast period.

In terms of current Combined Heat and Power (CHP) installed capacity, industrial and manufacturing segments in U.S. holds a major share as per the CHP Association. They can be use in various process industries including pulp and paper, chemicals, and petroleum refining. In terms of capacity expansion and orders, Middle East and Africa is likely to appear as the second regional segment. In 2016, this region was valued at more than USD 5,000 million. Increasing preference for gas-based combined cycle plants in oil and gas industry is expected to drive regional market over the forecast period.

Central and South America is also expected to create lucrative opportunities for clean energy in the forthcoming years. Countries such as Brazil, Chile, Peru, and Uruguay are the key regional markets for gas turbines. Active encouragement for cogeneration from Brazil is anticipated to bode well for regional demand in the forthcoming years.

Apart from China, Asia Pacific expected to show moderate growth due development of thermal-based power generation facilities and economic slowdown in Japan. However, rapid infrastructure development is expected to create opportunities in near future. India is expected to witness steady rise in demand for clean resources. China is likely to reduce its dependency on coal in near future and is likely to adopt clean energy sources. This factor is expected to support regional growth over the forecast period. China’s regional market is expected to expand at a CAGR of 5.2% through 2025.

Prominent players operating in the gas turbine market include Man Diesel & Turbo SE, Mitsubishi Hitachi Power Systems, Ltd., Siemens AG, Opra Turbines B.V., and Bharat Heavy Electricals Limited.

Browse More Reports Of The Same Category: www.grandviewresearch.com/industry/conventional-energy

Grand View Research has segmented the gas turbine market on the basis of capacity, technology, application, and region:

Gas Turbine Capacity Outlook (Volume, MW; Revenue, USD Million, 2014 - 2025)

• ≤200 MW
• >200 MW

Gas Turbine Technology Outlook (Volume, MW; Revenue, USD Million, 2014 - 2025)

• Open Cycle
• Combined Cycle

Gas Turbine Application Outlook (Volume, MW; Revenue, USD Million, 2014 - 2025)

• Power Generation
• Industrial
• Aviation

Gas Turbine Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
  • US
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East and Africa
  • Saudi Arabia

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-gas-turbine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gene Therapy Market Is Predicted To Reach $39.54 Million By 2026 With Growth Pace Of CAGR 19.1%

San Francisco, 28 Nov 2018  -  According to a report published by Grand View Research, Inc.; the global gene therapy market is expected to reach a valuation of over USD 39.54 billion by 2026. Significant number of molecules in pipeline is expected to drive market over the forecast period (2014 to 2026).

Gene therapy can cure rare as well as hereditary diseases caused by mutated or faulty gene. Increasing use in treatment of cardiovascular and rare diseases is one of the major trends supporting growth of market for gene therapy. In addition, rising requirement for new treatment options for orphan diseases and high prevalence of cancer due to gene mutations are expected to boost market growth in the forthcoming years.

In early 2016, more than 1000 molecule in pipeline were in various clinical phases. Approximately 76.0% of these molecules are in the developing or preclinical stages presently. They are expected to be launched by 2020. This factor is anticipated to bode well for overall market growth over the forecast period. However, high concerns related to unethical practices, especially in developing countries can hinder market growth to an extent. Very few drugs have received approvals by regulatory bodies across the world. Sky high prices of gene therapeutics are also anticipated to hinder commercial access for many regions.

Browse More Insights On Gene Therapy Market: www.grandviewresearch.com/industry-analysis/gene-therapy-market

The worldwide gene therapy market can be segmented on the basis of indication, vector type, and region. Based on indication, the market can be categorized into cancer, infectious diseases, cardio vascular diseases, neuro disorders, genetic disorders, and others. In 2017, cancer acquired the largest market share owing to presence of a large number of pipeline molecules. More than 60.0% of the market is occupied by cancer research. High incidence of cancer due to genetic mutation is expected to boost segment growth. Constant advancements in cancer gene studies have provided important information regarding cancer-related molecular signatures. This is also expected to support ongoing clinical trials.

On the basis of vector type, the market for gene therapy can be categorized into viral vectors and non-viral vectors. Modified viruses are the best vectors to deliver functioning gene to proposed cell target, according to scientists. Many viruses including Adeno-associated virus, herpes simplex virus, retrovirus, and lentivirus are modified in labs and are used as carriers in gene therapy drugs. Adenovirus is the most used viral vector followed by Retrovirus owing to their reduced immunogenicity. Every virus comprises disadvantage like limited DNA carrying ability or toxicity.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Europe and U.S. are expected to hold majority of market share during the forecast period. In terms of revenue, U.S. is expected to lead the market as more than 64.0% of all clinical trials conducted in the country. Asia Pacific is anticipated to expand at notable CAGR over the forecast period due to growth in pipeline molecules. Emerging countries such as China and Russia are likely to lead by an important margin as they have approved cancer therapy drugs.

Key companies operating in the gene therapy market include ReGenX Bio. Inc.; Dimension Therapeutics Inc.; Epeius Biotechnologies Corp; TaxusCardium Pharmaceuticals Inc.; and Biomarin Pharmaceuticals, Inc. Market growth mainly relies on crucial decisions made by manufacturers in terms of regulations, pricing, and reimbursement for treatment. Presence of a large number of pipeline molecules and intense competition among companies to augment their revenue growth is expected to drive the market in the forthcoming years.

Several startups are getting capital investments to support their research and development activities. Increasing emphasis on development of gene therapy for the treatment of rare diseases has led to competition among market players. Various established pharmaceutical and biotech companies are likely to acquire small firms. Many small companies are involved in development of in-house expertise and build their own pipelines. This factor is anticipated to create lucrative prospects for collaborations.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global gene therapy market by indication, vector type, and region:

Gene Therapy Indication Outlook (Revenue, USD Million, 2014 - 2026)

• Cancer
• Cardio Vascular Diseases
• Infectious Diseases
• Genetic Disorders
• Neuro Disorders
• Others

Gene Therapy Vector Type Outlook (Revenue, USD Million, 2014 - 2026)

• Viral Vectors
  • Retrovirus
  • Adenovirus
  • Adeno-associated virus
  • Vaccinia virus
  • Herpes simplex virus
  • Others
• Non-Viral Vectors
  • Injection of Naked DNA
  • Lipofection
  • Others

Gene Therapy Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• MEA
  • South Africa

Browse Press Release of this Report:  www.grandviewresearch.com/press-release/global-gene-therapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Amyloidosis Treatment Market Worth $6.7 Billion by 2025 | Key Industry Players Alnylam And Ionis

San Francisco, 27 Nov 2018 - The global amyloidosis treatment market size is expected to reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. Several factors such as increased adoption of novel targeted therapies and transplantations, emergence of biologics, and rising geriatric population are driving the market.

Amyloidosis is a group of rare diseases where misfolded aggregates of proteins (amyloids) buildup in tissues and organs. AL amyloidosis is the most common type of amyloidosis in U.S., with approximately 3,000 to 4,000 new cases diagnosed annually. Although in majority of cases, the disease is diagnosed in people over the age of 60, there are a few cases of people being diagnosed in their late 20s and about two-thirds of the patients are male.

Among treatments, chemotherapy held the largest share in 2017, followed by targeted therapy, and supportive care. However, targeted therapies are expected to dominate the market in 2025, supported by a strong pipeline and potential approval of drugs such as Alnylam’s Onpattro, Ionis’ Tegsedi, Johnson & Johnson’s Darzalex, and Takeda’s Ninlaro.

Stem cell transplants and targeted therapies are gaining traction in developed countries. However, amyloidosis cohorts in endemic regions do not have access to sufficient healthcare infrastructure to ensure prompt diagnosis and treatment in underdeveloped countries. Chemotherapy and supportive care are anticipated to lose market share over the forecast period due to adverse side effects and lower efficacy.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/amyloidosis-treatment-market

Further key findings from the report suggest:

• An estimated 16,000 people in U.S. suffer from amyloidosis, with approximately 3,000 to 4,000 new cases being reported annually
• S. dominated the global amyloidosis treatment market, with a share of more than 27.0% in 2017 due to potential launch of pipeline drugs, increased adoption of novel therapeutics, and high cost of treatment in the country
• Chemotherapy dominated the amyloidosis treatment market, with a share of about 35.0% in 2017. Targeted therapies are projected to witness double-digit growth during the forecast period due to multiple product approvals
• Emerging markets for amyloidosis such as China, Sweden, Portugal, Turkey, South Africa, Brazil, Mexico, Saudi Arabia, and India are expected to show attractive growth over the forecast period due to improved healthcare infrastructure, favorable government policies, increased investment, and large amyloidosis cohort
• Alnylam, Ionis, Pfizer, Johnson & Johnson and Takeda are some of the key players operating in this market
• Currently, 19 products are under evaluation for amyloidosis treatment in various stages of clinical development. Promising pipeline candidates such as Onpattro, Vyndaqel, Tegsedi, Darzalex, and Ninlaro are expected to generate significant revenue upon launch.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global amyloidosis treatment market based on treatment and country:

Amyloidosis Treatment Outlook (Revenue, USD Million, 2017 - 2025)

• Chemotherapy
• Supportive care
• Surgery
• Stem Cell Transplant
• Targeted Therapy

Amyloidosis Treatment Country Outlook (Revenue, USD Million, 2017 - 2025)

• US.
• Japan
• UK.
• Germany
• France
• Spain
• Italy

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-amyloidosis-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Global Botulinum Toxin Market Size To Reach USD 7.3 Billion By 2025 | Key Industry Players Allergan, Inc. & Ipsen Group

San Francisco, 27 Nov 2018 - The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/botulinum-toxin-market

Further Key Findings from the Study Suggest:

• The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.
• The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period
• In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan
• Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 - 2025)

• Botulinum Toxin Type A
• Botulinum Toxin Type B

End Use Outlook (Revenue, USD Million; 2013 - 2025)

• Therapeutic
• Aesthetic

Regional Outlook (Revenue, USD Million; 2013 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-botulinum-toxin-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Glucuronolactone Market Is Predicted To Reach $436.5 Million By 2024

San Francisco, 27 Nov 2018 - The global glucuronolactone market is expected to reach USD 436.5 million by 2024, according to a new report by Grand View Research, Inc. Growing consumer awareness towards the use of glucuronolactone in various food & beverage products including energy drinks and nutrition supplements will augment industry growth over the next eight years. Growing use of the product for manufacturing pharmaceutical drugs and health supplement is expected to fuel industry growth over the forecast period. The positive outlook towards sports nutrition in light of increasing importance of active lifestyle will promote market expansion.

           U.S. glucuronolactone market revenue, by end-use, 2013 - 2024 (USD Million)

Food & beverage was the prominent end-use segment and was valued at USD 155.1 million in 2015. Rising health conscious population in the urban region is expected to fuel demand growth over the forecast period. Rising disposable income, increasing health awareness, growing population in various countries including the U.S., Brazil, India and China will promote market growth over the upcoming years.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/glucuronolactone-market

Further key findings from the report suggest

• Pharmaceutical application will witness the fastest growth at a CAGR of 7.0% from 2014 to 2024 as a result of increasing usage of glucuronolactone based tablets and supplements to cure arthritis, hepatocirrhosis, and hepatitis. Furthermore, recovery of pharmaceutical industry in the U.S. is expected to drive market growth over the forecast period.
• North America glucuronolactone market was valued at USD 106.7 million in 2015 and will show significant rise owing to growing demand for energy drinks and nutritional supplements. Moreover, adoption of glucuronolactone as a supplement is also expected to fuel demand over the forecast period.
• Asia Pacific will witness significant growth at a CAGR of 6.6% from 2016 to 2024 in light of the high level of glucuronolactone producers in China, India, and Japan with a high level of exports. Moreover, abundant availability of the product in China is expected to have a positive impact on the market over the coming years. Growing pharmaceutical sector in China, India, Indonesia, Malaysia Philippines, Singapore, Thailand and Vietnam will stimulate industry expansion.
• Key manufacturers & exporters in the global glucuronolactone industry include Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck Millipore Corporation, and Shaoxing Marina Biotechnology Co., Ltd.
• Merck Millipore Corporation offers glucuronolactone produced by glucose oxidase and used as a nutritional supplement in pharmaceutical industries.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the global glucuronolactone market on the basis of end-use and region:

Global Glucuronolactone End-Use Outlook (Revenue, USD Million, 2013 - 2024)

• Food & Beverage
• Pharmaceuticals
• Others

Global Glucuronolactone Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• MEA

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-glucuronolactone-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Dairy Ingredients Market Is Poised To Reach USD 86.97 Billion By 2024

San Francisco, 27 Nov 2018 - According to a report by Grand View Research, Inc., global dairy ingredients market is anticipated to value USD 86.97 billion by 2024. Growing requirement for nutritional enrichment in food and beverages to maintain healthy lifestyle is anticipated to propel demand for dairy ingredients. Rising consumption of protein fortified functional food products is also fueling market growth. High demand for protein supplements in food items has resulted in development of new and innovative products. This, in turn, can augment growth of the global market over next few years.

                              Global dairy ingredients market, by application, 2015 (%)

Increasing use of diary ingredients in infant products for providing high heat stability, low microbiological levels, and facilitation of long processing runs during production can stimulate market growth. Supportive regulations by various regional governments regarding the use of dairy ingredients in food and drinks can also augment growth of the market during the forecast period (from 2016 to 2024). To cater to rising demand for dairy ingredients, most companies invest in R&D activities to develop advanced products. For instance, Kellogg recently launched fruit and oats harvest bars.

Browse Extensive Insights On Dairy Ingredients Market: www.grandviewresearch.com/industry-analysis/dairy-ingredients-market

Containing fruit and whole grains, these bars come in two flavors including country strawberry and blueberry bliss. These bars contain 4 grams of protein and 5 grams of fiber with less than 200 calories per bar. The dairy ingredients market can be segregated on the basis of product, application, and region. Based on product, the market can be categorized into buttermilk powder, cream powder, blenders and replacers, Skimmed Milk Powder (SMP), Whole Milk Powder (WMP), rolled dried powder, fat-filled powder, permeate powder/dried permeate, lactose and derivatives, casein and caseinate, MPC and MPI, and whey ingredients.

In 2015, SMP accounted for 23.3% of volume share. It is predicted to witness growth as SMP helps increase the shelf life of end-products due to less moisture content. Growing product demand in Ready-to-Use Foods (RUFs) or Fortified Blended Foods (FBFs) and therapeutic and supplementary foods owing to low fat and moisture content can also fuel the segment growth. The MPC and MPI segment is said to register a CAGR of 5.5 % from 2016 to 2024 attributed to high usage in baked goods, toppings, dairy-based dry mixes. They offer benefits, such as water binding, viscosity, and heat stability.

Based on application, the market can be classified into dairy products, convenience foods, infant milk formula, sports and clinical nutrition, bakery and confectionery, and others. In 2015, dairy products accounted for 38.5 % of the global volume. The segment is expected to witness significant growth due to rising demand for milk, yogurt, cream, ice cream, and lactose-free dairy products. Similarly, the chocolate segment is estimated to expand, in terms of volume, at CAGR of 4.3 % from 2016 to 2024. Rising consumption of chocolate owing to its stress relieving properties can fuel usage of milk powder.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA). In 2015, Asia Pacific led the market and accounted for 40.8 % of total volume. Regulatory efforts toward promoting investments in food & beverage sector of India and China can enhance the manufacturing capacity of sports nutrition and baked products. It is expected to remain a major driving factor for the market. The product demand in Europe was 3439.2 kilo tons in 2015. Increasing expenditure of sports of professionals and working individuals towards nutritional products in United Kingdom, France, Germany, and Russia for improving muscular strength can promote use of milk powder as functional ingredients.

In MEA, the market is expected to grow at CAGR of 3.1% from 2016 to 2024. Growing inclination of governments of countries including UAE, Saudi Arabia, and Qatar from upstream oil and gas sector for promoting investments in domestic food & beverage sector can create lucrative opportunities for market. Some of the leading companies in the global dairy ingredients market are Arla Foods; Volac International Ltd.; Dairy Farmers of America, Inc.; Fonterra Co-operative Group Ltd.; and Glanbia PLC.

Browse More Reports Of The Same Category: www.grandviewresearch.com/industry/ready-to-eat-processed-and-frozen-foods

Grand View Research has segmented the global dairy ingredients market by product, application and region:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)

• Skimmed Milk Powder (SMP)
• Whole Milk Powder (WMP)
• Buttermilk Powder
• Cream Powder
• Blenders & Replacers
• Rolled Dried Powder
• Fat-filled Powder
• Permeate Powder/Dried Permeate
• Lactose & Derivatives
• Casein & Caseinate
• MPC & MPI
• Whey Ingredients

Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)

• Bakery & Confectionery
  • Chocolate
  • Ice-Cream
  • Others
• Dairy Products
  • Recombinant Milk
  • Others
• Convenience Foods
• Infant Milk Formula
• Sports & Clinical Nutrition
• Others

Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Central & South America
• MEA

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-dairy-ingredients-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com